# Configurations

| UniProt Accession Number   | Reagent Type     | Target Name / Protein Biomarker   | Target Species   | Host Organism   | Isotype     | Clonality   | Vendor         |   Catalog Number | Conjugate   | RRID        | Availability   | Method                 | Tissue Preservation               | Target Tissue   | Tissue State   | Detergent         | Antigen Retrieval Conditions   | Dye Inactivation Conditions   | Recommend   | Agree                                                        | Disagree   | Contributor         | Notes       |
|:---------------------------|:-----------------|:----------------------------------|:-----------------|:----------------|:------------|:------------|:---------------|-----------------:|:------------|:------------|:---------------|:-----------------------|:----------------------------------|:----------------|:---------------|:------------------|:-------------------------------|:------------------------------|:------------|:-------------------------------------------------------------|:-----------|:--------------------|:------------|
| P20702                     | Primary Antibody | CD11c                             | Human            | Mouse           | BALB/c IgG1 | B-Ly6       | BD Biosciences |           561355 | FITC        | AB_10611872 | Stock          | IBEX2D Manual          | 1:4 Cytofix/Cytoperm Fixed Frozen | Lymph Node      | NA             | 0.3% Triton-X-100 | NA                             | 1 mg/ml LiBH4 30 minutes      | Yes         | 0000-0003-4379-8967 [[2](#publications), [1](#publications)] | NA         | 0000-0003-4379-8967 | [1](#notes) |
| P20702                     | Primary Antibody | CD11c                             | Human            | Mouse           | IgG1        | 3.9         | BioLegend      |           301603 | FITC        | AB_314173   | Stock          | Multiplexed 2D Imaging | 1:4 Cytofix/Cytoperm Fixed Frozen | Lymph Node      | NA             | 0.3% Triton-X-100 | NA                             | NA                            | No          | 0000-0003-4379-8967                                          | NA         | 0000-0003-4379-8967 | [2](#notes) |

# Publications

<a name="publications"></a>
1. A. J. Radtke et al., "IBEX: an iterative immunolabeling and chemical bleaching
 method for high-content imaging of diverse tissues", *Nat. Protoc.*, 17(2):378-401, 2022, [doi: 10.1038/s41596-021-00644-9](https://doi.org/10.1038/s41596-021-00644-9).

    A. J. Radtke et al., "Accompanying dataset for: IBEX: An iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissues", [doi: 10.5281/zenodo.5244550](https://doi.org/10.5281/zenodo.5244551).

2. A. J. Radtke et al., "IBEX: A versatile multiplex optical imaging approach for deep phenotyping and spatial analysis of cells in complex tissues", *Proc Natl Acad Sci*, 117(52):33455â€“33465, 2020, [doi:10.1073/pnas.2018488117](https://doi.org/10.1073/pnas.2018488117)


# Additional Notes

<a name="notes"></a>
1. B-ly6 is a preferred clone for human CD11c. This clone performs well in many different formats (AF700 included in IBEX experiments).
2. This antibody labels dendritic cells in human lymph nodes and colocalizes with HLA-DR (clone L243). B-ly6 is the preferred clone for human CD11c.
